Velarion Records
Free. Unsubscribe any time.

Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics, Inc. filed 7 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 7 transactions and 92,642 shares. 5 carry the SEC's AFF10B5ONE flag; 2 name a plan only in a footnote. 7 results prints are on file in the same window.

What stands out

Trades in Artiva Biotherapeutics, Inc. 7

Adoption dates in Artiva Biotherapeutics, Inc. 3

Results prints in Artiva Biotherapeutics, Inc. 7

Trades before a print in Artiva Biotherapeutics, Inc. 0

Interval to Artiva Biotherapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Artiva Biotherapeutics, Inc. states

Filing text: “10b5-1 Plan adopted by the reporting person on July 23, 2024”

Reported results dates on file

A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.

Other companies with plan records

Sources: SEC EDGAR full-text search and the SEC submissions API.